Pharmacy2U Announce an Increase in Sun Cream Products Leeds, United Kingdom (August 20, 2010) – Pharmacy2U, the UK’s largest online pharmacy, announce an increase in the number of people purchasing sun cream products to protect their skin from the summer sun. Pharmacy2U believe that most people in this day and age are aware of the [...]

World’s Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients ZURICH, July 19, 2010 / WorldPRLine / — Today, Novo Nordisk announced the landmark recruitment of the 60,000th patient in the A1chieve(R) study – an observational study designed to investigate the effects of modern insulins in the management of type 2 diabetes.[1] Spanning 28 [...]

Frost & Sullivan: Imminent Launch of Small-molecule Antiviral Drugs Poised to Enhance Treatment Success Rates for Hepatitis C Patients SINGAPORE, July 15, 2010 / WorldPRLine / — Efforts to raise disease awareness in the Philippines have increased the number of cases and patient pool available for hepatitis C treatment. Screening and detection efforts by the [...]

ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina LEUVEN, Belgium, July 15, 2010 / WorldPRLine / — Paper Highlights the Potential of Microplasmin for Nonsurgical Treatment of Vitreomacular Adhesion ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular [...]

ThromboGenics to Present Results of Second Phase III Trial of Microplasmin at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress LEUVEN, Belgium, July 1, 2010 / WorldPRLine / — ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments [...]

Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology Collaboration aims to accelerate human genome analysis and enable advancements in personalized healthcare YORKTOWN HEIGHTS, N.Y. and BRANFORD, Conn., July 1, 2010  / WorldPRLine / — Roche (SIX: RO, ROG; OTCQX: RHHBY) and IBM (NYSE: IBM) announced today an agreement to develop a nanopore-based technology [...]

Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome STOCKHOLM, June 30, 2010 / WorldPRLine / — Agreement Marks Milestone in Pharmalink’s Corporate Development Pharmalink AB, today announced that it has closed its agreement with Grifols SA for the acquisition of Pharmalink’s Xepol(R) programme [...]

The New Future of Healthcare in Germany: Innovative Clinical Services Designed to Enhance Care, Reduce Costs for Sick Fund Medco, BIG direkt gesund in agreement that could forge a new frontier in pharmacy-driven clinical care FRANKLIN LAKES, N.J., and BERLIN, June 25, 2010  / WorldPRLine / — Medco Health Solutions and BIG direkt gesund today [...]

IDEV Technologies Enters Into an Exclusive Distribution Agreement With TriReme Medical WEBSTER, Texas, June 24, 2010 / WorldPRLine / — IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced that it has entered into an exclusive distribution agreement covering the U.S. and Germany for TriReme [...]

Miltenyi Biotec Announces Release of Viscover(TM) Preclinical Contrast Agents for in vivo Small Animal Imaging BERLIN and BERGISCH GLADBACH, Germany, June 16, 2010 / WorldPRLine / — Miltenyi Biotec today announces the worldwide release of the Viscover(TM) product line, offering researchers an unrivaled range of preclinical contrast agents for small animal in vivo imaging. Viscover [...]